There is little information about the regulation of alternative splicing in leukemias, although the levels of specific splicing regulatory factors are altered in tumors, can affect the alternative splicing of some genes, including c-myb, and can act as oncogenes in some situations [31]. This evidence concerns the gene MYB and leukemia.